|
|
Office Locations:
|
1585 Broadway, 39th Floor
New York, NY 10036
Phone: 212-761-8753
Fax: 212-507-3971
| | |
|
|
|
|
|
Consumer Products & Services
Information Technology
Life Sciences & Healthcare
Media & Digital Media
Software & Internet
|
|
|
|
Morgan Stanley Expansion Capital invests in later-stage, private emerging growth companies in technology and other high growth sectors including healthcare, consumer and digital media. Morgan Stanley has a long and successful history growth investing. Since 1986, Expansion Capital and its predecessor, Morgan Stanley Venture Partners, have invested over $1.1 billion of growth capital in over 150 companies. The firm has offices in New York and San Francisco. Expansion Capital targets later-stage investments in technology, healthcare, consumer, digital media, and other high growth sectors. We seek companies largely beyond the development-risk phase and that have demonstrated customer and market validation. While the firm does not require profitable operations for prospective investments, capital efficiency is emphasized. Morgan Stanley targets a $5-15 million investment.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
